Does VINORELBINE Cause Agranulocytosis? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Agranulocytosis have been filed in association with VINORELBINE (Vinorelbine). This represents 1.3% of all adverse event reports for VINORELBINE.
66
Reports of Agranulocytosis with VINORELBINE
1.3%
of all VINORELBINE reports
2
Deaths
41
Hospitalizations
How Dangerous Is Agranulocytosis From VINORELBINE?
Of the 66 reports, 2 (3.0%) resulted in death, 41 (62.1%) required hospitalization, and 30 (45.5%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINORELBINE. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does VINORELBINE Cause?
Off label use (644)
Malignant neoplasm progression (624)
Disease progression (526)
Neutropenia (517)
Nausea (504)
Drug ineffective (391)
Fatigue (373)
Diarrhoea (371)
Vomiting (342)
Anaemia (335)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which VINORELBINE Alternatives Have Lower Agranulocytosis Risk?
VINORELBINE vs VINORELBINE\VINORELBINE
VINORELBINE vs VIREAD
VINORELBINE vs VISIPAQUE
VINORELBINE vs VISMODEGIB
VINORELBINE vs VITAMIN A